Best Practices for IBS Diagnostics & Treatment
with Dr. Shanti Eswaran | Michigan Medicine
Irritable Bowel Syndrome (IBS) affects an estimated 10-15% of the worldwide population with up to 45 million people living with this functional GI disorder daily. Its one of the most burdensome chronic ailments reported by GI patients, and in a survey by IFFGD, nearly 2,000 patients reported that they suffered from IBS symptoms for 6.6 years before being diagnosed.
In honor of IBS Awareness Month (April) and World IBS Day (April 19th), CDI hosted a GI Community discussion with Dr. Shanti Eswaran, a Gastroenterologist at Michigan Medicine and Clinical Associate Professor of Internal Medicine at University of Michigan’s School of Medicine.
In the 30-minute discussion and Q&A led by CDI’s President and & CEO Craig Strasnick, Dr. Eswaran discussed best practices for diagnosing and treating patients with Irritable Bowel Syndrome. Topics include:
- Optimizing the management and care of IBS patients through integrated care
- The role of diet and diet modifications for IBS patients
- The link between IBS and other functional GI disorders like Small Intestinal Bacterial Overgrowth (SIBO)
New Guide Available: A Pro-Forma Comparison of Breath Testing Models for Gastrointestinal Disorders
Functional GI Diagnostic Test Orders
Submit your patient diagnostic orders. We will process your order ASAP!